TERT Promoter C228T and C250T Hotspot Mutations Are Absent in BRAF V600E-Positive Langerhans Cell Histiocytosis. [PDF]
Silva AMD +3 more
europepmc +1 more source
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701). [PDF]
Masuishi T +28 more
europepmc +1 more source
Determinación de BRAF V600E por biopsia líquida en oncología de precisión. [PDF]
Alonso VA, Mendeluk GR.
europepmc +1 more source
A Systematic Review of the Diagnostic Role of BRAF V600E Testing in Thyroid Nodules with Atypia of Undetermined Significance. [PDF]
Saleem N +3 more
europepmc +1 more source
Mitoxantrone hydrochloride injection guided sentinel lymph node biopsy in cN0 BRAF V600E-mutated papillary thyroid carcinoma: a feasibility study. [PDF]
Li Z, Li C, Li J, Song T, Men X, Wang Y.
europepmc +1 more source
Prognostic significance of BRAF V600E and TERT promoter mutations in radioiodine resistance and recurrence of differentiated thyroid cancer. [PDF]
Nhung LTT +9 more
europepmc +1 more source
Successful Treatment of BRAF V600E-Mutant Intrahepatic Cholangiocarcinoma With Encorafenib, Binimetinib, and Cetuximab. [PDF]
Yamaguchi T +9 more
europepmc +1 more source
Validation of preoperative BRAF V600E testing by ThyroSCAN PanelChip in thyroid nodules. [PDF]
Lee PS +8 more
europepmc +1 more source
Association Between <i>BRAF V600E</i> Allele Frequency and Aggressive Behavior in Papillary Thyroid Microcarcinoma. [PDF]
Tatar L +7 more
europepmc +1 more source
BRAF V600E-Mutant Diffuse Pulmonary Langerhans Cell Histiocytosis Successfully Treated With Dabrafenib Plus Trametinib: A Case Report. [PDF]
Sakurai A +10 more
europepmc +1 more source

